Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nezih Meydan

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Molecular and Clinical Oncology|March 21, 2014
Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancerUmut Varol, Esin Oktay, Mustafa Yildirim, et al.
Tumori|July 9, 2004
Paclitaxel-carboplatin induced radiation recall colitisIsil Kundak, Ilhan Oztop, Mujde Soyturk, et al.
Journal of Cancer Research and Therapeutics|December 13, 2018
The prognostic role of thyroid transcription factor-1 in lung adenocarcinomaEsin Oktay, Utku Oflazoglu, Yelda Varol, et al.
Journal of Cancer Research and Therapeutics|September 15, 2020
The prognostic role of thyroid transcription factor-1 in lung adenocarcinomaEsin Oktay, Utku Oflazoglu, Yelda Varol, et al.
Medical Oncology (Northwood, London, England)|September 14, 2014
Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches GroupOzgur Tanriverdi, Suna Cokmert, Esin Oktay, et al.
The Clinical Respiratory Journal|December 28, 2016
Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancerMuhyettin Omar, Ozgur Tanriverdi, Suna Cokmert, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 1, 2015
Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches GroupOzgur Tanriverdi, Nilufer Avci, Esin Oktay, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2020
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational studyMustafa Benekli, Mahmut Gumus, Metin Ozkan, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|April 4, 2015
Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial)Nuri Faruk Aykan, Suayib Yalçın, N Serdar Turhal, et al.
Targeted Oncology|September 24, 2024
Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective TrialFeride Yılmaz, Serkan Yaşar, Nil Molinas Mandel, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Molecular and Clinical Oncology|March 21, 2014
Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancerUmut Varol, Esin Oktay, Mustafa Yildirim, et al.
Tumori|July 9, 2004
Paclitaxel-carboplatin induced radiation recall colitisIsil Kundak, Ilhan Oztop, Mujde Soyturk, et al.
Journal of Cancer Research and Therapeutics|December 13, 2018
The prognostic role of thyroid transcription factor-1 in lung adenocarcinomaEsin Oktay, Utku Oflazoglu, Yelda Varol, et al.
Journal of Cancer Research and Therapeutics|September 15, 2020
The prognostic role of thyroid transcription factor-1 in lung adenocarcinomaEsin Oktay, Utku Oflazoglu, Yelda Varol, et al.
Medical Oncology (Northwood, London, England)|September 14, 2014
Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches GroupOzgur Tanriverdi, Suna Cokmert, Esin Oktay, et al.
The Clinical Respiratory Journal|December 28, 2016
Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancerMuhyettin Omar, Ozgur Tanriverdi, Suna Cokmert, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 1, 2015
Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches GroupOzgur Tanriverdi, Nilufer Avci, Esin Oktay, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2020
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational studyMustafa Benekli, Mahmut Gumus, Metin Ozkan, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|April 4, 2015
Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial)Nuri Faruk Aykan, Suayib Yalçın, N Serdar Turhal, et al.
Targeted Oncology|September 24, 2024
Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective TrialFeride Yılmaz, Serkan Yaşar, Nil Molinas Mandel, et al.
Pageof 5